Artificial Pancreas Device System (APDS) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The global artificial pancreas device systems market accounted for US$ 481.8 Mn in 2017 and is expected to grow at a CAGR of 20% during the forecast period 2021 – 2027, to account for US$ 2,168.1Mn by 2027.

The artificial pancreas device system consists of two types of devices for monitoring diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose meter used to calibrate the CGM (such as a glucose meter). These devices are intended to reduce hypoglycemic exodus by automatically stopping insulin administration for up to two hours when an individual’s glucose level falls below a preset level if the individual does not respond to a threshold suspend alarm. In 2016, the MiniMed 670G system (Medtronic), a hybrid closed-loop insulin delivery system, received FDA approval. This device is the first fully automated artificial pancreatic device system. It consists of an insulin pump, a blood glucose meter, a transmitter connected with a proprietary algorithm, and a SmartGuard Hybrid Closed Loop.

Market Segments

By Device Type

• Threshold suspended device system
• CTR System
• CTT System

Key Players

• Defymed
• TypeZero Technologies, Inc.
• Insulet Corporation
• Bigfoot Biomedical, Inc.
• Medtronic
• Dexcom, Inc.
• Admetsys
• Beta Bionics
• Cellnovo
• Tandem Diabetes Care, Inc.

Scope of the Report

The research study analyzes the global Artificial Pancreas Device System (APDS) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Artificial Pancreas Device System (APDS) Market Report

1. What was the Artificial Pancreas Device System (APDS) Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Artificial Pancreas Device System (APDS) Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Artificial Pancreas Device System (APDS) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.